TW vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

TW

36.8
AI Score
VS
TW Wins

CME

32.8
AI Score

Investment Advisor Scores

TW

37score
Recommendation
EXTENDED

CME

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric TW CME Winner
Forward P/E 25.974 21.9298 CME
PEG Ratio 1.6235 4.7092 TW
Revenue Growth 9.0% 0.8% TW
Earnings Growth 19.7% 2.5% TW
Tradestie Score 36.8/100 32.8/100 TW
Profit Margin 40.7% 63.4% CME
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY TW

Relative Price Performance (Last 90 Days)

TW 1M: +21.2% · 3M: +20.1% CME 1M: +13.7% · 3M: +19.7%

Current Technical Phase

TW

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 82

RSI (14): 81.9 · Price: $122.57

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 78

RSI (14): 77.9 · Price: $305.71

Fundamentals Snapshot

Metric TW CME
Market Cap — —
Forward P/E 26.6 23.2
Trailing P/E 29.2 24.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.9% 1.0%
Operating Margin 0.4% 0.7%
EPS 4.18 12.62
Dividend Yield 0.00% 0.00%

Frequently Asked Questions

Based on our detailed analysis, TW is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.